Matches in SemOpenAlex for { <https://semopenalex.org/work/W70059979> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W70059979 endingPage "134" @default.
- W70059979 startingPage "125" @default.
- W70059979 abstract "Conventional therapy of pancreatic exocrine cancer is disappointing. The poor prognosis of the disease challenges development of novel therapeutic strategies. We report the results of clinical trials of the monoclonal antibody (Mab) 17-1A in patients with histologically verified unresectable pancreatic exocrine cancer. No antitumor response was seen in 18 patients treated with Mab 17-1A (500 mg) admixed with 109 autologous mono nuclear cells, and 81% of the patients developed antimouse antibody response. Combination of recombinant gamma interferon and Mab 17-1A mixed with autologous mononuclear white cells resulted in complete response of 4-mo duration in 1 out of 25 evaluable patients and unusually stable disease from 4 to 48+mo in another 6 patients. High intermittent doses of infused Mab 17-1A did not show any objective antitumor response and caused serious anaphylaxis in two of the patients in the trial. Because examination of six pancreatic adenocarcinoma cell lines with different doses of Mab 17-1A and IL-2 failed to augment lytic activity of mono nuclear effector cells against all cancer cell lines tested, there seemed to be no rationale for pursuing clinical studies with IL-2 and Mab 17-1A in either the murine or chimeric form. Attractive therapeutic approaches include active immunotherapy with immunization using idiotypic antibodies or targeted toxicity with the use of radioimmunoconjugates, particularly125I-labeled chimeric Mab 17-1A." @default.
- W70059979 created "2016-06-24" @default.
- W70059979 creator A5002872975 @default.
- W70059979 creator A5014009418 @default.
- W70059979 creator A5071303565 @default.
- W70059979 creator A5074392921 @default.
- W70059979 creator A5079728565 @default.
- W70059979 creator A5087004487 @default.
- W70059979 date "1991-06-01" @default.
- W70059979 modified "2023-09-26" @default.
- W70059979 title "Immunotherapy with Monoclonal Antibody (Mab) in Pancreatic Adenocarcinoma" @default.
- W70059979 cites W11928235 @default.
- W70059979 cites W1565037697 @default.
- W70059979 cites W1655373893 @default.
- W70059979 cites W1942676258 @default.
- W70059979 cites W1975199388 @default.
- W70059979 cites W1981218638 @default.
- W70059979 cites W2014760168 @default.
- W70059979 cites W2016236483 @default.
- W70059979 cites W2040505385 @default.
- W70059979 cites W2052688313 @default.
- W70059979 cites W2078837657 @default.
- W70059979 cites W2081549751 @default.
- W70059979 cites W2084785317 @default.
- W70059979 cites W2132331648 @default.
- W70059979 cites W2150891458 @default.
- W70059979 cites W2161137930 @default.
- W70059979 cites W2237805390 @default.
- W70059979 cites W2265537752 @default.
- W70059979 cites W2333946063 @default.
- W70059979 cites W2412872000 @default.
- W70059979 cites W2416767262 @default.
- W70059979 cites W2434360090 @default.
- W70059979 doi "https://doi.org/10.1007/bf02925588" @default.
- W70059979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1744438" @default.
- W70059979 hasPublicationYear "1991" @default.
- W70059979 type Work @default.
- W70059979 sameAs 70059979 @default.
- W70059979 citedByCount "6" @default.
- W70059979 crossrefType "journal-article" @default.
- W70059979 hasAuthorship W70059979A5002872975 @default.
- W70059979 hasAuthorship W70059979A5014009418 @default.
- W70059979 hasAuthorship W70059979A5071303565 @default.
- W70059979 hasAuthorship W70059979A5074392921 @default.
- W70059979 hasAuthorship W70059979A5079728565 @default.
- W70059979 hasAuthorship W70059979A5087004487 @default.
- W70059979 hasConcept C121608353 @default.
- W70059979 hasConcept C126322002 @default.
- W70059979 hasConcept C159654299 @default.
- W70059979 hasConcept C203014093 @default.
- W70059979 hasConcept C2776737053 @default.
- W70059979 hasConcept C2777701055 @default.
- W70059979 hasConcept C2778764654 @default.
- W70059979 hasConcept C2780210213 @default.
- W70059979 hasConcept C2781182431 @default.
- W70059979 hasConcept C502942594 @default.
- W70059979 hasConcept C542903549 @default.
- W70059979 hasConcept C71924100 @default.
- W70059979 hasConceptScore W70059979C121608353 @default.
- W70059979 hasConceptScore W70059979C126322002 @default.
- W70059979 hasConceptScore W70059979C159654299 @default.
- W70059979 hasConceptScore W70059979C203014093 @default.
- W70059979 hasConceptScore W70059979C2776737053 @default.
- W70059979 hasConceptScore W70059979C2777701055 @default.
- W70059979 hasConceptScore W70059979C2778764654 @default.
- W70059979 hasConceptScore W70059979C2780210213 @default.
- W70059979 hasConceptScore W70059979C2781182431 @default.
- W70059979 hasConceptScore W70059979C502942594 @default.
- W70059979 hasConceptScore W70059979C542903549 @default.
- W70059979 hasConceptScore W70059979C71924100 @default.
- W70059979 hasIssue "1" @default.
- W70059979 hasLocation W700599791 @default.
- W70059979 hasLocation W700599792 @default.
- W70059979 hasOpenAccess W70059979 @default.
- W70059979 hasPrimaryLocation W700599791 @default.
- W70059979 hasRelatedWork W2013099682 @default.
- W70059979 hasRelatedWork W2019775514 @default.
- W70059979 hasRelatedWork W2023039187 @default.
- W70059979 hasRelatedWork W2043890160 @default.
- W70059979 hasRelatedWork W2100999260 @default.
- W70059979 hasRelatedWork W2152393478 @default.
- W70059979 hasRelatedWork W2764038087 @default.
- W70059979 hasRelatedWork W2789659603 @default.
- W70059979 hasRelatedWork W3013358603 @default.
- W70059979 hasRelatedWork W4225811843 @default.
- W70059979 hasVolume "9" @default.
- W70059979 isParatext "false" @default.
- W70059979 isRetracted "false" @default.
- W70059979 magId "70059979" @default.
- W70059979 workType "article" @default.